Effect of atorvastatin,cholesterol ester transfer protein inhibition,and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Effect of atorvastatin,cholesterol ester transfer protein inhibition,and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk

Authors:	Benoit J. Arsenault Francine Petrides Fatiha Tabet Weihang Bao G. Kees Hovingh S. Matthijs Boekholdt Stéphane Ramin-Mangata Olivier Meilhac David DeMicco Kerry-Anne Rye David D. Waters John J.P. Kastelein Philip Barter Gilles Lambert

Affiliation:	1. Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Québec, Canada;2. Department of Medicine, Faculty of Medicine, Université Laval, Québec, Québec, Canada;3. School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia;4. Pfizer Inc, New York, NY, USA;5. Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands;6. Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands;7. Inserm, UMR 1188 DéTROI, Université de La Réunion, Sainte-Clotilde, France;8. Division of Cardiology, University of California, San Francisco, CA, USA

Abstract:

Keywords:	Atorvastatin Diabetes mellitus Lipoprotein(a) PCSK9 CETP
本文献已被 ScienceDirect 等数据库收录！